Verne Bio
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Verne Bio is a biotechnology company that provides rapid, scalable genetic and pathogen testing services and kits for the cannabis and hemp industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Environmental Monitoring
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Verne Bio Comparables
Compare Verne Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TUMI Genomics | 91% | |
| MyFloraDNA, Inc. | 91% | |
| Courtagen Life Sciences | 83% |
Verne Bio Funding Rounds
Historical fundraising activity
Verne Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Massachusetts Biomedical Initiatives | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 64% MoM, reaching 4K.
- Mar 3, 2026
Monthly visitors grew 47% MoM, reaching 3K.
Verne Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Verne Bio's valuation, stock price, and market status.
Is Verne Bio a public or private company?
Verne Bio is a private company.
What is the current stock price of Verne Bio?
Verne Bio is a private company, so its shares have no public market price. Caplight tracks Verne Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Verne Bio worth (valuation)?
Valuation information for Verne Bio is not publicly available.
Can I buy Verne Bio stock?
Verne Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Verne Bio's last funding round?
Funding round information for Verne Bio is not publicly available.
Who are the main investors in Verne Bio?
Key investors in Verne Bio include Massachusetts Biomedical Initiatives.
Will Verne Bio IPO soon?
No public IPO plans have been announced for Verne Bio.
How can I track Verne Bio secondary market activity?
Caplight tracks bids, offers, and trades in Verne Bio's shares on secondary markets.